본문으로 건너뛰기
← 뒤로

Innovative Immunotherapy and Its Transformative Impact on Gastric Adenocarcinoma: A Comprehensive Review of the Disease's Origins, Epidemiology, Classification, Diagnosis, and Treatment Options.

ACS pharmacology & translational science 2025 Vol.8(6) p. 1438-1472

Upasana, Kanugo A, Bhattacharya S

📝 환자 설명용 한 줄

This review provides a thorough summary of gastric cancer (GC), including its categorization, etiology, diagnosis, and the emerging use of immunotherapy in its treatment.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Upasana, Kanugo A, Bhattacharya S (2025). Innovative Immunotherapy and Its Transformative Impact on Gastric Adenocarcinoma: A Comprehensive Review of the Disease's Origins, Epidemiology, Classification, Diagnosis, and Treatment Options.. ACS pharmacology & translational science, 8(6), 1438-1472. https://doi.org/10.1021/acsptsci.4c00677
MLA Upasana, et al.. "Innovative Immunotherapy and Its Transformative Impact on Gastric Adenocarcinoma: A Comprehensive Review of the Disease's Origins, Epidemiology, Classification, Diagnosis, and Treatment Options.." ACS pharmacology & translational science, vol. 8, no. 6, 2025, pp. 1438-1472.
PMID 40534682

Abstract

This review provides a thorough summary of gastric cancer (GC), including its categorization, etiology, diagnosis, and the emerging use of immunotherapy in its treatment. It investigates the Correa Cascade, a development from normal mucosa to adenocarcinoma, and discusses the global incidence and mortality rates of GC. The article discusses the Lauren Classification, WHO classification, and tumor staging, emphasizing the necessity of early detection for optimal care. It investigates the different causes of GC, including , Epstein-Barr Virus, hereditary and environmental variables, and describes the diagnostic procedures utilized for early detection. Finally, this review aims to provide an in-depth breakdown and overview of the most important topics in GC and immunotherapy, including disease development, classification, risk factors, early detection methods, treatment options, and the growing significance of immunotherapy, as well as the importance of biomarkers, ongoing clinical trials, and immunotherapy's potential to treat GC.

같은 제1저자의 인용 많은 논문 (1)